Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 34, 2022 - Issue 4
1,600
Views
0
CrossRef citations to date
0
Altmetric
Research Article

ART initiation among women newly diagnosed with HIV in a contraceptive trial in sub-Saharan Africa

ORCID Icon, , , , , ORCID Icon, , ORCID Icon, , , , , , & show all
Pages 478-485 | Received 08 Jan 2021, Accepted 07 Jun 2021, Published online: 27 Jun 2021

References

  • Ahmed, S., Autrey, J., Katz, I. T., Fox, M. P., Rosen, S., Onoya, D., Bärnighausen, T., Mayer, K. H., & Bor, J. (2018). Why do people living with HIV not initiate treatment? A systematic review of qualitative evidence from low- and middle-income countries. Social Science & Medicine (1982), 213, 72–84. https://doi.org/10.1016/j.socscimed.2018.05.048
  • Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H., Godbole, S. V., Chariyalertsak, S., Santos, B. R., Mayer, K. H., Hoffman, I. F., Eshleman, S. H., Piwowar-Manning, E., Cottle, L., Zhang, X. C. … HPTN 052 Study Team. (2016). Antiretroviral therapy for the prevention of HIV-1 transmission. The New England Journal of Medicine, 375(9), 830–839. https://doi.org/10.1056/NEJMoa1600693
  • Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. (2019). HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: A randomised, multicentre, open-label trial. Lancet (London, England), 394(10195), 303–313. https://doi.org/10.1016/S0140-6736(19)31288-7
  • The Government of the Kingdom of Eswatini. (2018). The National Multisectoral HIV and AIDS Strategic Framework (NSF) 2018–2023. https://hivpreventioncoalition.unaids.org/wp-content/uploads/2019/06/Eswatini_NSF-2018-2023_final.pdf
  • Grey, G. E., & Presentation of HVTN702 Study Data. (2020). Proceedings of the Conference on retroviruses and opportunitistic infections (CROI), Virtual, 8-11 March 2020. http://www.croiwebcasts.org/console/player/44778?mediaType=audio&
  • Human Sciences Research Council, South Africa. (2018). HIV Impact Assessment Summary: The Fifth South African National HIV Prevalence, Incidence, Behaviour and Communication Survey, 2017. http://www.hsrc.ac.za/uploads/pageContent/9237/SABSSMV_Impact_Assessment_Summary_ZA_ADS_cleared3.pdf
  • Larsen, A., Cheyip, M., Tesfay, A., Vranken, P., Fomundam, H., Wutoh, A., & Aynalem, G. (2019). Timing and predictors of initiation on antiretroviral therapy among newly-diagnosed HIV-Infected persons in South Africa. AIDS and Behavior, 23(2), 375–385. https://doi.org/10.1007/s10461-018-2222-2
  • Lee, M. J., Venturelli, S., McKenna, W., Teh, J., Negedu, O., Florman, K. E., Musbahi, E., Bailey, A. C., Mackie, N. E., Fox, J., & Fidler, S. (2019). Reasons for delayed antiretroviral therapy (ART) initiation in the era of early ART initiation guidelines: A retrospective service evaluation. International Journal of STD & AIDS, 30(4), 415–418. https://doi.org/10.1177/0956462418814985
  • INSIGHT START Study Group, Lundgren, J. D., Babiker, A. G., Gordin, F., Emery, S., Grund, B., Sharma, S., Avihingsanon, A., Cooper, D. A., Fätkenheuer, G., Llibre, J. M., Molina, J. M., Munderi, P., Schechter, M., Wood, R., Klingman, K. L., Collins, S., Lane, H. C., Phillips, A. N., & Neaton, J. D. (2015). Initiation of antiretroviral therapy in early asymptomatic HIV infection. The New England Journal of Medicine, 373(9), 795–807. https://doi.org/10.1056/NEJMoa1506816
  • Maughan-Brown, B., Smith, P., Kuo, C., Harrison, A., Lurie, M. N., Bekker, L. G., & Galárraga, O. (2018). Readiness for antiretroviral therapy: Implications for linking HIV-Infected individuals to care and treatment. AIDS and Behavior, 22(3), 691–700. https://doi.org/10.1007/s10461-017-1834-2
  • Ministry of Health, National AIDS & STI Control Programme. (2016). Guidelines on use of antiretroviral drugs for treating and preventing HIV infection in Kenya, 2016 edition. NASCOP.
  • Ministry of Health, Zambia. (2017). Zambia population-based HIV impact assessment (ZAMPHIA) 2016: First Report. Zambia, Ministry of Health. https://phia.icap.columbia.edu/wp-content/uploads/2017/11/FINAL-ZAMPHIA-First-Report_11.30.17_CK.pdf
  • National AIDS and STI Control Programme (NASCOP). (2020). Preliminary KENPHIA 2018 Report. Nairobi: NASCOP; 2020. Nairobi: NASCOP. https://phia.icap.columbia.edu/wp-content/uploads/2020/04/KENPHIA-2018_Preliminary-Report_final-web.pdf
  • Nhassengo, P., Cataldo, F., Magaço, A., Hoffman, R. M., Nerua, L., Saide, M., Cuco, R., Hoek, R., Mbofana, F., Couto, A., Gudo, E., Chicumbe, S., & Dovel, K. (2018). Barriers and facilitators to the uptake of test and treat in Mozambique: A qualitative study on patient and provider perceptions. PloS one, 13(12), e0205919. https://doi.org/10.1371/journal.pone.0205919
  • Pell, C., Vernooij, E., Masilela, N., Simelane, N., Shabalala, F., & Reis, R. (2018). False starts in ‘test and start': A qualitative study of reasons for delayed antiretroviral therapy in Swaziland. International Health, 10(2), 78–83. https://doi.org/10.1093/inthealth/ihx065
  • Plazy, M., Newell, M. L., Orne-Gliemann, J., Naidu, K., Dabis, F., & Dray-Spira, R. (2015). Barriers to antiretroviral treatment initiation in rural KwaZulu-Natal, South Africa. HIV Medicine, 16(9), 521–532. https://doi.org/10.1111/hiv.12253
  • Pry, J., Chipungu, J., Smith, H. J., Bolton Moore, C., Mutale, J., Duran-Frigola, M., Savory, T., & Herce, M. E. (2020). Patient-reported reasons for declining same-day antiretroviral therapy initiation in routine HIV care settings in Lusaka, Zambia: Results from a mixed-effects regression analysis. Journal of the International AIDS Society, 23(7), e25560. https://doi.org/10.1002/jia2.25560
  • Republic of Zambia, Ministry of Health. (2016). Zambia consolidated guidelines for treatment & prevention of HIV infection. http://www.differentiatedcare.org/Portals/0/adam/Content/fLl-2LVqM0izU06VDY6DqQ/File/Zambia_Consolidated_2016_Guidelines.pdf
  • Sabapathy, K., Mubekapi-Musadaidzwa, C., Mulubwa, C., Schaap, A., Hoddinott, G., Stangl, A., Floyd, S., Ayles, H., Fidler, S., Hayes, R., & HPTN 071 (PopART) study team. (2017). Predictors of timely linkage-to-ART within universal test and treat in the HPTN 071 (PopART) trial in Zambia and South Africa: Findings from a nested case-control study. Journal of the International AIDS Society, 20(4), e25037. https://doi.org/10.1002/jia2.25037
  • South African National Department of Health. (2019). 2019 ART clinical guidelines for the management of HIV in adults, pregnancy, adolescents, children, infants and neonates. https://www.knowledgehub.org.za/system/files/elibdownloads/2020-05/2019%20ART%20Guideline%2028042020%20pdf.pdf
  • Swaziland Ministry of Health. (2017). Swaziland HIV incidence measurement survey 2: A population-based HIV impact assessment: SHIMS2 2016–2017. http://phia.icap.columbia.edu/wp-content/uploads/2017/11/Swaziland_new.v8.pdf
  • Sy, K., Tariq, S., Ramjee, G., Blanchard, K., Leu, C. S., Kelvin, E. A., Exner, T. M., Gandhi, A. D., Lince-Deroche, N., Mantell, J. E., O'Sullivan, L. F., & Hoffman, S. (2021). Predictors of antiretroviral therapy initiation in eThekwini (Durban), South Africa: Findings from a prospective cohort study. PloS one, 16(2), e0246744. https://doi.org/10.1371/journal.pone.0246744
  • World Health Organization (WHO). (2015). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. https://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/
  • World Health Organization (WHO). (2017). Fact sheet: TREAT ALL: Policy adoption and implementation status in Countries. Retrieved November 9, 2020, from https://apps.who.int/iris/bitstream/handle/10665/258538/WHO-HIV-2017.35-eng.pdf?ua=1
  • Zou, G. (2004). A modified poisson regression approach to prospective studies with binary data. American Journal of Epidemiology, 159(7), 702–706. https://doi.org/10.1093/aje/kwh090